Moderna, one of the leading horses in the coronavirus vaccine race, has already made deals at between $32 and $37 a dose for some foreign countries. The U.S. price is expected to be lower.
Adjuvants play a crucial role in many vaccines' effectiveness. Some scientists say there needs to be more research into developing a wider variety of adjuvants because of how important they are.
Dr. Paul Offit, who serves on the Food and Drug Administration's vaccine advisory board, says he doesn't think an effective vaccine that's undergone adequate testing can be ready this year.
Many of the buildings where we lived out our pre-coronavirus days have been largely empty and idle.
Now, some experts are warning that idle buildings may have become breeding grounds for another disease which, like coronavirus, causes severe lung illness, pneumonia and sometimes death.
The Food and Drug Administration has approved a fast-acting nasal spray to treat suicidal patients. The spray contains a chemical cousin of the anesthetic and party drug ketamine.
With the flu season looming, public health officials urge nearly all Americans over 6 months old to get immunized starting next month. Strategize now to avoid getting the flu while COVID-19 is raging.
Vaccine candidates are in advanced clinical trials, and WHO's director-general expresses hope they will be effective. But until then, he said, the world is reliant on "the basics" of disease control.
For many cancer patients, daily life can feel full of risky choices involving work, family, friends and money. Nearly every option pits the risks of catching the coronavirus against other downsides.
Public health officials say a promising coronavirus vaccine is on its way in 2021. But does that matter if only half of Americans say they're willing to get such a vaccination?
The hospital said it made a humane decision to end treatment. Michael Hickson's widow says doctors ended his care because they underestimated the life of a man with significant disabilities.
The National Institutes of Health is giving $248.7 million dollars to seven companies developing new technologies for testing, including use of the revolutionary gene-editing technique CRISPR.
Studies involving COVID-19 vaccine candidates in monkeys show promise of an effective vaccine, but it will take large-scale human trials to know for sure if they work.
Scientists are now checking to see if purified blood serum from people who have recovered from COVID-19 might be more than a useful treatment. Perhaps it's a way to prevent disease in someone else.
